The concept of stem cell in the mammary gland and its implication in morphogenesis, cancer and prevention

Frontiers in Bioscience

Volumn 11, Issue 1 P.1-446, 2006, Pages 151-172

  Russo, Jose ^a   Balogh, Gabriela A ^a   Chen, Jinqiang ^a   Fernandez, Sandra V ^a   Fernbaugh, Rachael ^a   Heulings, Rebecca ^a   Mailo, Daniel A ^a   Moral, Raquel ^a   Russo, Patricia A ^a   Sheriff, Fathima ^a   Vanegas, Johana E ^a   Wang, Richard ^a   Russo, Irma H ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Cancer; Differentiation; Mammary gland; Pregnancy; Prevention; Review; Stem cell

Indexed keywords

RODENTIA;

EID: 32844473892     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1788     Document Type: Review

References (129)

1. J Russo & I H Russo: Development of human mammary gland. In: The Mammary Gland Development, Regulation and Function. Eds: Neville M C, Daniel C. Plenum Publishing Corp., New York. 67-93 (1987)
2. Russo J, R. Rivera & I. H. Russo: Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 23, 211-218 (1992)
3. Russo J & I. H. Russo: Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 3, 353-364 (1994)
4. Russo J, B. A. Gusterson, A. E. Rogers, I. H. Russo, S. R. Wellings & M. J. van Zwieten: Comparative study of human and rat mammary tumorigenesis. Lab Invest 62, 244-278 (1990)
5. Wellings S. R, H. M. Jensen & R. G. Marcum: An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55, 231-273 (1975)
6. Russo J, A. L. Romero & I. H. Russo: Architectural pattern of the normal and cancerous breast under the influence of parity. Cancer Epidemiol Biomarkers Prev 3, 219-224 (1994)
7. Russo J, H. Lynch & I. H. Russo: Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J 7, 278-291 (2001)
8. Russo J & I. H. Russo: Role of differentiation in the pathogenesis and prevention of breast cancer. J of Endocrinology, Endocrine-Related Cancer 4, 7-21 (1997)
9. Deome K. B, L. J. Faulkin, Jr., H. A. Bern & P. B. Blair: Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 19, 515-520 (1959)
10. Kordon E. C & G. H. Smith: An entire functional mammary gland may comprise the progeny from a single cell. Development 125, 1921-1930 (1998)
11. Russo J, J. Saby, W. Isenberg & I. H. Russo: Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 59, 436-445(1977)
12. Russo J, W. Isenberg, M. Ireland & I. H. Russo: Ultrastructural changes in the mammary epithelial cell population during neoplastic development induced by a chemical carcinogen. In: Electron Microscopy Society of America Proceedings. Vol. 34. Electron Microscopy Society of America. 250-251 (1976)
13. Russo J, L. Tait & I. H. Russo: Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma. Am J Pathol 113, 50-66 (1983)
14. Russo J, L. K. Tay & I. H. Russo: Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2, 5-73 (1982)
15. Bennett D. C, L. A. Peachey, H. Durbin & P. S. Rudland: A possible mammary stem cell line. Cell 15, 283-298 (1978)
16. Rudland P. S, D. C. Bennett & M. J. Warburton: Isolation and characterization of epithelial stem-cell cell lines from the rat mammary gland. Br J Cancer 41, 666-668 (1980)
17. Chepko G & G. H. Smith: Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell 29, 239-253 (1997)
18. Smith G. H, T. Mehrel & D. R. Roop: Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium. Cell Growth Differ 1, 161-170 (1990)
19. Stingl J, C. J. Eaves, U. Kuusk & J. T. Emerman: Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation 63, 201-213 (1998)
20. Stingl J, C. J. Eaves, I. Zandieh & J. T. Emerman: Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat 67, 93-109 (2001)
21. Hebbard L, A. Steffen, V. Zawadzki, C. Fieber, N. Howells, J. Moll, H. Ponta, M. Hofmann & J. Sleeman: CD44 expression and regulation during mammary gland development and function. J Cell Sci 113 (Pt 14), 2619-2630 (2000)
22. Kenney N. J, G. H. Smith, E. Lawrence, J. C. Barren & D. S. Salomon: Identification of stem cell units in the terminal end bud and duct of the mouse mammary Gland. J Biomed Biotechnol 1, 133-143 (2001)
23. Spangrude G. J, Y. Aihara, I. L. Weissman & J. Klein: The stem cell antigens Sca-1 and Sca-2 subdivide thymic and peripheral T lymphocytes into unique subsets. J Immunol 141, 3697-3707 (1988)
24. Welm B. E, S. B. Tepera, T. Venezia, T. A. Graubert, J. M. Rosen & M. A. Goodell: Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 245, 42-56 (2002)
25. Zhou S, J. D. Schuetz, K. D. Bunting, A. M. Colapietro, J. Sampath, J. J. Morris, I. Lagutina, G. C. Grosveld, M. Osawa, H. Nakauchi & B. P. Sorrentino: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7, 1028-1034 (2001)
26. Alvi A. J, H. Clayton, C. Joshi, T. Enver, A. Ashworth, M. M. Vivanco, T. C. Dale & M. J. Smalley: Functional and molecular characterisation of mammary side population cells. Breast Cancer Res 5, R1-8 (2003)
27. Gudjonsson T, R. Villadsen, H. L. Nielsen, L. Ronnov-Jessen, M. J. Bissell & O. W. Petersen: Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev 16, 693-706 (2002)
28. Dontu G, W. M. Abdallah, J. M. Foley, K. W. Jackson, M. F. Clarke, M. J. Kawamura & M. S. Wicha: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17, 1253-1270 (2003)
29. Jia Y, C. Qi, Z. Zhang, Y. T. Zhu, S. M. Rao & Y. J. Zhu: Peroxisome proliferator-activated receptor-binding protein null mutation results in defective mammary gland development. J Biol Chem 280, 10766-10773 (2005)
30. Couse J. F & K. S. Korach: Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20, 358-417 (1999)
31. Russo J, X. Ao, C. Grill & I. H. Russo: Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 53, 217-227 (1999)
32. Petersen O. W, T. Gudjonsson, R. Villadsen, M. J. Bissell & L. Ronnov-Jessen: Epithelial progenitor cell lines as models of normal breast morphogenesis and neoplasia. Cell Prolif 36 Suppl 1, 33-44 (2003)
33. Clarke R. B, E. Anderson, A. Howell & C. S. Porten: Regulation of human breast epithelial stem cells. Cell Prolif 36 Suppl 1, 45-58 (2003)
34. Clarke R. B, K. Spence, E. Anderson, A. Howell, H. Okano & C. S. Potten: A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 277, 443-456 (2005)
35. Clayton H, I. Titley & M. Vivanco: Growth and differentiation of progenitor/stem cells derived from the human mammary gland. Exp Cell Res 297, 444-460 (2004)
36. Whitehead R. H, S. J. Quirk, A. A. Vitali, J. W. Funder, R. L. Sutherland & L. C. Murphy: A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness. J Natl Cancer Inst 73, 643-648 (1984)
37. Brannvall K, L. Korhonen & D. Lindholm: Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation. Mol Cell Neurosci 21, 512-520 (2002)
38. Miura T, C. Miura, T. Ohta, M. R. Nader, T. Todo & K. Yamauchi: Estradiol-17beta stimulates the renewal of spermatogonial stem cells in males. Biochem Biophys Res Commun 264, 230-234 (1999)
39. Kuiper G. G, E. Enmark, M. Pelto-Huikko, S. Nilsson & J. A. Gustafsson: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93, 5925-5930 (1996)
40. Ogawa S, S. Inoue, T. Watanabe, H. Hiroi, A. Orimo, T. Hosoi, Y. Chichi & M. Muramatsu: The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem Biophys Res Commun 243, 122-126 (1998)
41. Balfe P. J, A. H. McCann, H. M. Welch & M. J. Kerin: Estrogen receptor beta and breast cancer. Eur J Surg Oncol 30, 1043-1050 (2004)
42. Skliris G. P, K. Munot, S. M. Bell, P. J. Carder, S. Lane, K. Horgan, M. R. Lansdown, A. T. Parkes, A. M. Hanby, A. F. Markham & V. Speirs: Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J Pathol 201, 213-220 (2003)
43. Paruthiyil S, H. Parmar, V. Kerekatte, G. R. Cunha, G. L. Firestone & D. C. Leitman: Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64, 423-428 (2004)
44. Shaaban A. M, P. A. O'Neill, M. P. Davies, R. Sibson, C. R. West, P. H. Smith & C. S. Foster: Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia. Am J Surg Pathol 27, 1502-1512 (2003)
45. Krege J. H, J. B. Hodgin, J. F. Couse, E. Enmark, M. Warner, J. F. Mahler, M. Sar, K. S. Korach, J. A. Gustafsson & O. Smithies: Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 95, 15677-15682 (1998)
46. Korach K. S, J. F. Couse, S. W. Curtis, T. F. Washburn, J. Lindzey, K. S. Kimbro, E. M. Eddy, S. Migliaccio, S. M. Snedeker, D. B. Lubahn, D. W. Schomberg & E. P. Smith: Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 51, 159-186; discussion 186-158 (1996)
47. Weihua Z, S. Makela, L. C. Andersson, S. Salmi, S. Saji, J. I. Webster, E. V. Jensen, S. Nilsson, M. Warner & J. A. Gustafsson: A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci U S A 98, 6330-6335 (2001)
48. Weihua Z, S. Saji, S. Makinen, G. Cheng, E. V. Jensen, M. Warner & J. A. Gustafsson: Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Proc Natl Acad Sci U S A 97, 5936-5941 (2000)
49. Weihua Z, M. Warner & J. A. Gustafsson: Estrogen receptor beta in the prostate. Mol Cell Endocrinol 193, 1-5 (2002)
50. Jensen E. V, G. Cheng, C. Palmieri, S. Saji, S. Makela, S. Van Noorden, T. Wahlstrom, M. Warner, R. C. Coombes & J. A. Gustafsson: Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci U S A 98, 15197-15202 (2001)
51. Clarke R. B, A. Howell & E. Anderson: Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res Treat 45, 121-133 (1997)
52. Clarke R. B, A. Howell, C. S. Porten & E. Anderson: Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57, 4987-4991 (1997)
53. Tonetti D. A, R. Rubenstein, M. DeLeon, H. Zhao, S. G. Pappas, D. J. Bentrem, B. Chen, A. Constantinou & V. Craig Jordan: Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells. J Steroid Biochem Mol Biol 87, 47-55 (2003)
54. Gustafsson J. A & M. Warner: Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer. J Steroid Biochem Mol Biol 74, 245-248 (2000)
55. Saji S, E. V. Jensen, S. Nilsson, T. Rylander, M. Warner & J. A. Gustafsson: Estrogen receptors alpha and beta in the rodent mammary gland. Proc Natl Acad Sci U S A 97, 337-342 (2000)
56. Saji S, H. Sakaguchi, S. Andersson, M. Warner & J. Gustafsson: Quantitative analysis of estrogen receptor proteins in rat mammary gland. Endocrinology 142, 3177-3186 (2001)
57. Foley E. F, A. A. Jazaeri, M. A. Shupnik, O. Jazaeri & L. W. Rice: Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 60, 245-248 (2000)
58. Iwao K, Y. Miyoshi, C. Egawa, N. Ikeda & S. Noguchi: Quantitative analysis of estrogen receptor-beta mRNA and its variants in human breast cancers. Int J Cancer 88, 733-736 (2000)
59. Roger P, M. E. Sahla, S. Makela, J. A. Gustafsson, P. Baldet & H. Rochefort: Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61, 2537-2541 (2001)
60. Rutherford T, W. D. Brown, E. Sapi, S. Aschkenazi, A. Munoz & G. Mor: Absence of estrogen receptor-beta expression in metastatic ovarian cancer. Obstet Gynecol 96, 417-421 (2000)
61. Leygue E, H. Dotzlaw, P. H. Watson & L. C. Murphy: Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res 58, 3197-3201 (1998)
62. Speirs V, A. T. Parkes, M. J. Kerin, D. S. Walton, P. J. Carleton, J. N. Fox & S. L. Atkin: Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Res 59, 525-528 (1999)
63. Speirs V, C. Malone, D. S. Walton, M. J. Kerin & S. L. Atkin: Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res 59, 5421-5424 (1999)
64. Speirs V, I. P. Adams, D. S. Walton & S. L. Atkin: Identification of wild-type and exon 5 deletion variants of estrogen receptor beta in normal human mammary gland. J Clin Endocrinol Metab 85, 1601-1605 (2000)
65. Speirs V & M. J. Kerin: Prognostic significance of oestrogen receptor beta in breast cancer. Br J Surg 87, 405-409 (2000)
66. Swain S. M: Tamoxifen for patients with estrogen receptor-negative breast cancer. J Clin Oncol 19, 93S-97S (2001)
67. Chang H. G, S. J. Kim, K. W. Chung, D. Y. Noh, Y. Kwon, E. S. Lee & H. S. Kang: Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene. J Mol Med 83, 132-139 (2005)
68. Shim G. J, L. Wang, S. Andersson, N. Nagy, L. L. Kis, Q. Zhang, S. Makela, M. Warner & J. A. Gustafsson: Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci U S A 100, 6694-6699 (2003)
69. Imamov O, A. Morani, G. J. Shim, Y. Omoto, C. Thulin-Andersson, M. Wamer & J. A. Gustafsson: Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci U S A 101, 9375-9380 (2004)
70. Pais V, I. Leav, K. M. Lau, Z. Jiang & S. M. Ho: Estrogen receptor-beta expression in human testicular germ cell tumors. Clin Cancer Res 9, 4475-4482 (2003)
71. Palmieri C, S. Saji, H. Sakaguchi, G. Cheng, A. Sunters, M. J. O'Hare, M. Warner, J. A. Gustafsson, R. C. Coombes & E. W. Lam: The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts. J Mol Endocrinol 33, 35-50 (2004)
72. Russo J, M. Hasan Lareef, G. Balogh, S. Guo & I. H. Russo: Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 87, 1-25 (2003)
73. Hu Y. F, K. M. Lau, S. M. Ho & J. Russo: Increased expression of estrogen receptor beta in chemically transformed human breast epithelial cells. Int J Oncol 12, 1225-1228 (1998)
74. Russo J, M. H. Lareef, Q. Tahin, Y. F. Hu, C. Slater, X. Ao & I. H. Russo: 17Beta-estradiol is carcinogenic in human breast epithelial cells. J Steroid Biochem Mol Biol 80, 149-162 (2002)
75. Lareef M. H, J. Garber, P. A. Russo, I. H. Russo, R. Heulings & J. Russo: The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. Int J Oncol 26, 423-429 (2005)
76. Fernandez S. V, I. H. Russo, M. Lareef, B. Balsara & J. Russo: Comparative genomic hybridization of human breast epithelial cells transformed by estrogen and its metabolites. Int J Oncol 26, 691-695 (2005)
77. Kehrl J. H: Hematopoietic lineage commitment: role of transcription factors. Stem Cells 13, 223-241 (1995)
78. Shivdasani R. A & S. H. Orkin: Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc Natl Acad Sci USA 92, 8690-8694 (1995)
79. Tsai S, S. Bartelmez, E. Sitnicka & S. Collins: Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 8, 2831-2841 (1994)
80. Briggs J. A, G. R. Burrus, B. D. Stickney & R. C. Briggs: Cloning and expression of the human myeloid cell nuclear differentiation antigen: regulation by interferon alpha. J Cell Biochem 49, 82-92 (1992)
81. Briggs R, L. Dworkin, J. Briggs, E. Dessypris, J. Stein, G. Stein & J. Lian: Interferon alpha selectively affects expression of the human myeloid cell nuclear differentiation antigen in late stage cells in the raonocytic but not the granulocytic lineage. J Cell Biochem 54, 198-206 (1994)
82. Briggs R. C, J. A. Briggs, J. Ozer, L. Sealy, L. L. Dworkin, S. F. Kingsmore, M. F. Seldin, G. P. Kaur, R. S. Athwal & E. N. Dessypris: The human rayeloid cell nuclear differentiation antigen gene is one of at least two related interferon-inducible genes located on chromosome 1q that are expressed specifically in hematopoietic cells. Blood 83, 2153-2162 (1994)
83. Briggs R. C, W. Y. Kao, L. L. Dworkin, J. A. Briggs, E. N. Dessypris & J. Clark: Regulation and specificity of MNDA expression in monocytes, macrophages, and leukemia/B lymphoma cell lines. J Cell Biochem 56, 559-567 (1994)
84. Hamada T, K. Tashiro, H. Tada, J. Inazawa, M. Shirozu, K. Shibahara, T. Nakamura, N. Martina, T. Nakano & T. Honjo: Isolation and characterization of a novel secretory protein, stromal cell-derived factor-2 (SDF-2) using the signal sequence trap method. Gene 176, 211-214 (1996)
85. Lindahl T, M. S. Satoh, G. G. Poirier & A, Klungland: Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 20, 405-411 (1995)
86. Menissier-de Murcia J, M. Molinete, G. Gradwohl, F. Simonin & G. de Murcia: Zinc-binding domain of poly(ADP-ribose)polymerase participates in the recognition of single strand breaks on DNA. J Mol Biol 210, 229-233 (1989)
87. Boulikas T: Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation) (review). Anticancer Res 11, 489-527 (1991)
88. Althaus F. R, L. Hofferer, H. E. Kleczkowska, M. Malanga, H. Naegeli, P. L. Panzeter & C. A. Realini: Histone shuttling by poly ADP-ribosylation. Mol Cell Biochem 138, 53-59 (1994)
89. Malanga M, J. M. Pleschke, H. E. Kleczkowska & F. R. Althaus: Poly(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions. J Biol Chem 273, 11839-11843 (1998)
90. Pleschke J. M, H. E. Kleczkowska, M. Strohm & F. R. Althaus: Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J Biol Chem 275, 40974-40980 (2000)
91. Zahradka P & K. Ebisuzaki: A shuttle mechanism for DNA-protein interactions. The regulation of poly(ADP-ribose) polymerase. Eur J Biochem 127, 579-585 (1982)
92. Le Rhun Y, J. B. Kirkland & G. M. Shah: Cellular responses to DNA damage in the absence of Poly(ADP-ribose) polymerase. Biochem Biophys Res Commun 245, 1-10 (1998)
93. Cosi C & M. Marien: Implication of poly (ADP-ribose) polymerase (PARP) in neurodegeneration and brain energy metabolism. Decreases in mouse brain NAD+ and ATP caused by MPTP are prevented by the PARP inhibitor benzamide. Am N Y Acad Sci 890, 227-239 (1999)
94. Ha H. C & S. H. Snyder: Poly(ADP-ribose) polymerase-1 in the nervous system. Neurobiol Dis 7, 225-239 (2000)
95. Pieper A. A, A. Verma, J. Zhang & S. H. Snyder: Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sco 20, 171-181 (1999)
96. Park Y. C, H. Ye, C. Hsia, D. Segal, R. L. Rich, H. C. Liou, D. G. Myszka & H. Wu: A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 101, 777-787 (2000)
97. Kanai F, P. A. Marignani, D. Sarbassova, R. Yagi, R. A. Hall, M. Donowitz, A. Hisaminato, T. Fujiwara, Y. Ito, L. C. Cantley & M. B. Yaffe: TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. Embo J 19, 6778-6791 (2000)
98. Sudol M: Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 9, 2145-2152 (1994)
99. Bedford M. T, D. Sarbassova, J. Xu, P. Leder & M. B. Yaffe: A novel pro-Arg motif recognized by WW domains. J Biol Chem 275, 10359-10369 (2000)
100. Cooper H. M, R. N. Tamura & V. Quaranta: The major laminin receptor of mouse embryonic stem cells is a novel isoform of the alpha 6 beta 1 integrin. J Cell Biol 115, 843-850 (1991)
101. MacMahon B, P. Cole, T. M. Lin, C. R. Lowe, A. P. Mirra, B. Ravnihar, E. J. Salber, V. G. Valaoras & S. Yuasa: Age at first birth and breast cancer risk. Bull World Health Organ 43, 209-221 (1970)
102. Lambe M, C. C. Hsieh, H. W. Chan, A. Ekbom, D. Trichopoulos & H. O. Adami: Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat 38, 305-311 (1996)
103. Kelsey J. L, M. D. Gammon & E. M. John: Reproductive factors and breast cancer. Epidemiol Rev 15, 36-47 (1993)
104. R C Moon: Influence of pregnancy and lactation on experimental mammary carcinogenesis. In: Banbury Report 8 Hormones and Breast Cancer. Eds: Pike M C, Siiteri P K, Welsch C W. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 353-364 (1981)
105. Sinha D. K, J. E. Pazik & T. L. Dao: Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy. Br J Cancer 57, 390-394 (1988)
106. Yang J, K. Yoshizawa, S. Nandi & A. Tsubura: Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. Carcinogenesis 20, 623-628 (1999)
107. Welsch C. W: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res 45, 3415-3443 (1985)
108. Russo J & I. H. Russo: Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res 40, 2677-2687 (1980)
109. Swanson S. M, L. M. Whitaker, C. R. Stockard, R. B. Myers, D. Oelschlager, W. E. Grizzle, M. M. Juliana & C. J. Grubbs: Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer. Anticancer Res 17, 4639-4645 (1997)
110. Rajkumar L, R. C. Guzman, J. Yang, G. Thordarson, F. Talamantes & S. Nandi: Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci U S A 98, 11755-11759 (2001)
111. Tay L. K & J. Russo: Formation and removal of 7, 12-dimethylbenz[a] anthracene-nucleic acid adducts in rat mammary epithelial cells with different susceptibility to carcinogenesis. Carcinogenesis 2, 1327-1333 (1981)
112. Russo I. H, M. Koszalka & J. Russo: Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br J Cancer 64, 481-484 (1991)
113. Thordarson G, E. Jin, R. C. Guzman, S. M. Swanson, S. Nandi & F. Talamantes: Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis 16, 2847-2853 (1995)
114. Wagner K. U, C. A. Boulanger, M. D. Henry, M. Sgagias, L. Hennighausen & G. H. Smith: An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 129, 1377-1386 (2002)
115. Henry M. D, A. A. Triplett, K. B. Oh, G. H. Smith & K. U. Wagner: Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene 23, 6980-6985 (2004)
116. Boulanger C. A, K. U. Wagner & G. H. Smith: Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-betal expression. Oncogene 24, 552-560 (2005)
117. Trichopoulos D, P. Lagiou & H. O. Adami: Towards an integrated model for breast cancer etiology: the crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res 7, 13-17 (2005)
118. Srivastava P, J. Russo & I. H. Russo: Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Carcinogenesis 18, 1799-1808 (1997).
119. Srivastava P, J. Russo & I. H. Russo: Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin associated with increased expression of inhibin. Mol Carcinog 26, 10-19 (1999)
120. Medina D & F. S. Kitrrell: p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res 63, 6140-6143 (2003)
121. Medina D: Breast cancer: the protective effect of pregnancy. Clin Cancer Res 10, 380S-384S (2004)
122. Sivaraman L, O. M. Conneely, D. Medina & B. W. O'Malley: p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci U S A 98, 12379-12384 (2001)
123. Ginger M. R, M. F. Gonzalez-Rimbau, J. P. Gay & J. M. Rosen: Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol 15, 1993-2009 (2001)
124. Ginger M. R & J. M. Rosen: Pregnancy-induced changes in cell-fate in the mammary gland. Breast Cancer Res 5, 192-197 (2003)
125. D'Cruz C. M, S. E. Moody, S. R. Master, J. L. Hartman, E. A. Keiper, M. B. Imielinski, J. D. Cox, J. Y. Wang, S. I. Ha, B. A. Keister & L. A. Chodosh: Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 16, 2034-2051 (2002)
126. J Russo & I H Russo: Endocrine control of breast development. In: molecular basis of breast cancer: Prevention and treatment. Eds: Russo J, Russo I H Springer-Verlag, Berlin, Heidelberg, New York. 64-67 (2004)
127. Russo I. H & J. Russo: Role of hCG and inhibin in breast cancer. Int J Cancer 4, 297-306 (1997)
128. Greenlee R. T, T. Murray, S. Bolden & P. A. Wingo: Cancer statistics, 2000. CA Cancer J Clin 50, 7-33 (2000)
129. Russo J, R. Moral, G. A. Balogh, D. Mailo & I. H. Russo: The protective role of pregnancy in breast cancer. Breast Cancer Res 7, 131-142 (2005)